Logotyp Captor Therapeutics
European Union logo Programy ABM
  • About us
  • Science
  • Pipeline
  • Strategy
  • News
  • Investor Relations

    Overview

    • About Captor
    • Strategy

    Management

    • Management Board
    • Supervisory Board

    General Meetings

    Corporate Documents and Governance

    • Corporate Documents
    • FAQ

    Shares and Related Information

    • Shares
    • Stock Price
    • Shareholders
    • Capital Market Institutions

    Reports

    • Current
    • Periodic

    Finance

    • Selected Financial Data
    • Dividend Policy
    • Incentive Scheme
    • Covering Analysts

    Investor Resources and Calendar

    • Presentations & Posters
    • Calendar
    • Media Kit

    Contact

  • Careers
  • Contact
  • PL
  • |
  • EN
  • About us
  • Science
  • Pipeline
  • Strategy
  • News
  • Investor Relations
    • OVERVIEW
      • About Captor
      • Strategy
    • MANAGEMENT
      • Management Board
      • Supervisory Board
    • GENERAL MEETINGS
    • CORPORATE DOCUMENTS AND GOVERNANCE
      • Corporate Documents
      • FAQ
    • SHARES AND RELATED INFORMATION
      • Shares
      • Stock Price
      • Shareholders
      • Capital Market Institutions
    • REPORTS
      • Current
      • Periodic
    • FINANCE
      • Selected Financial Data
      • Dividend Policy
      • Incentive Scheme
      • Covering Analysts
    • INVESTOR RESOURCES AND CALENDAR
      • Presentations & Posters
      • Calendar
      • Media Kit
    • CONTACT
  • Careers
  • Contact
  • PL
  • |
  • EN
  • Home
  • News

Captor Therapeutics ®

News

  • Journalist
  • Science
miniatura
September 23, 2023
Captor Therapeutics will raise PLN 40 million from share issue for implementation of strategic goals
more
miniatura
September 11, 2023
Captor Therapeutics appoints Wedbush as its exclusive strategic financial advisor and establishes relationship with MSQ Ventures in China
more
miniatura
September 08, 2023
Captor Therapeutics publishes financial report for the first half of 2023
more
miniatura
July 18, 2023
Captor Therapeutics with PLN 52.2 million co-funding from The Medical Research Agency of Poland
more
miniatura
May 29, 2023
Captor Therapeutics publishes Q1 2023 financial results
more
miniatura
April 07, 2023
Captor Therapeutics has published its 2022 report. The past year was a period of dynamic growth for the Company in both science and business.
more
miniatura
March 27, 2023
Captor Therapeutics Discloses Molecular Targets of Pipeline’s Lead Assets and Invites Stakeholders to Webcast
more
miniatura
March 06, 2023
Captor Therapeutics Announces Three-Year Strategic Objectives
more
  • 1
  • 2
  • 3
  • 4
Logotyp Captor Therapeutics
linkedin logo Linkedin twitter logo Twitter Privacy Policy
  • About us
  • Optigrade Platform
  • Pipeline
  • News
  • Investor Relations
  • Careers
  • Contact
© 2022 Captor Therapeutics All rights reserved Projekt i realizacja: Artneo.pl